Literature DB >> 9538490

Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin.

G V Gill1.   

Abstract

A case is presented of a young competitive body-builder who abused anabolic steroid drugs and developed profound symptomatic hypogonadotrophic hypogonadism. With the help of prescribed testosterone (Sustanon) he stopped taking anabolic drugs, and later stopped Sustanon also. Hypogonadism returned, but was successfully treated with weekly injections of human chorionic gonadotropin for three months. Testicular function remained normal thereafter on no treatment. The use of human chorionic gonadotropin should be considered in prolonged hypogonadotrophic hypogonadism due to anabolic steroid abuse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538490      PMCID: PMC2360778          DOI: 10.1136/pgmj.74.867.45

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  Misusing anabolic drugs.

Authors:  H M Perry; B N Littlepage
Journal:  BMJ       Date:  1992-11-21

Review 2.  Testicular steroidogenesis and androgen use and abuse.

Authors:  F C Wu
Journal:  Baillieres Clin Endocrinol Metab       Date:  1992-04

3.  Anabolic steroid-induced hypogonadotropic hypogonadism.

Authors:  J P Jarow; L I Lipshultz
Journal:  Am J Sports Med       Date:  1990 Jul-Aug       Impact factor: 6.202

Review 4.  Androgen abuse by athletes.

Authors:  J D Wilson
Journal:  Endocr Rev       Date:  1988-05       Impact factor: 19.871

5.  Drug abuse in body builders in the West of Scotland.

Authors:  G McKillop
Journal:  Scott Med J       Date:  1987-04       Impact factor: 0.729

Review 6.  Androgens in men--uses and abuses.

Authors:  C J Bagatell; W J Bremner
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

7.  Neuropsychiatric effects of anabolic steroids in male normal volunteers.

Authors:  T P Su; M Pagliaro; P J Schmidt; D Pickar; O Wolkowitz; D R Rubinow
Journal:  JAMA       Date:  1993-06-02       Impact factor: 56.272

8.  Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes.

Authors:  H Martikainen; M Alén; P Rahkila; R Vihko
Journal:  J Steroid Biochem       Date:  1986-07       Impact factor: 4.292

Review 9.  Anabolic steroids in athletics: how well do they work and how dangerous are they?

Authors:  D R Lamb
Journal:  Am J Sports Med       Date:  1984 Jan-Feb       Impact factor: 6.202

10.  Estimated prevalence of anabolic steroid use among male high school seniors.

Authors:  W E Buckley; C E Yesalis; K E Friedl; W A Anderson; A L Streit; J E Wright
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

  10 in total
  6 in total

1.  Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.

Authors:  Taylor P Kohn; Matthew R Louis; Stephen M Pickett; Mark C Lindgren; Jaden R Kohn; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Fertil Steril       Date:  2016-11-14       Impact factor: 7.329

2.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

Review 3.  Anabolic steroids: a review for the clinician.

Authors:  Eric C Kutscher; Brian C Lund; Paul J Perry
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

4.  Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility.

Authors:  J R Kovac; J Scovell; R Ramasamy; S Rajanahally; R M Coward; R P Smith; L I Lipshultz
Journal:  Andrologia       Date:  2014-09-15       Impact factor: 2.775

Review 5.  Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use.

Authors:  J Abram McBride; Robert M Coward
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

Review 6.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.